Short Interest in Masimo Corporation (NASDAQ:MASI) Rises By 21.2%

Masimo Corporation (NASDAQ:MASI) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,248,048 shares, an increase of 21.2% from the March 15th total of 2,680,885 shares. Based on an average daily volume of 1,934,658 shares, the short-interest ratio is currently 1.7 days. Currently, 6.7% of the shares of the stock are sold short.

Institutional Trading of Masimo

Large investors have recently added to or reduced their stakes in the company. SG Americas Securities LLC lifted its holdings in shares of Masimo by 3,082.3% in the first quarter. SG Americas Securities LLC now owns 522,824 shares of the medical equipment provider’s stock valued at $92,995,000 after purchasing an additional 506,395 shares in the last quarter. Evolve Private Wealth LLC acquired a new stake in shares of Masimo in the first quarter worth $305,000. Diversified Trust Co purchased a new position in shares of Masimo during the first quarter valued at $833,000. Corient Private Wealth LLC raised its position in Masimo by 1.2% during the fourth quarter. Corient Private Wealth LLC now owns 340,230 shares of the medical equipment provider’s stock valued at $44,250,000 after buying an additional 4,015 shares during the period. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Masimo during the fourth quarter valued at $116,000. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Stock Performance

Masimo stock opened at $178.29 on Friday. Masimo has a fifty-two week low of $125.94 and a fifty-two week high of $179.00. The firm’s 50 day simple moving average is $170.75 and its 200-day simple moving average is $151.73. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47. The company has a market cap of $9.58 billion, a P/E ratio of -16.92, a price-to-earnings-growth ratio of 1.81 and a beta of 1.20.

Wall Street Analyst Weigh In

Several research analysts have issued reports on MASI shares. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Piper Sandler cut Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a report on Tuesday, February 17th. Stifel Nicolaus set a $180.00 target price on Masimo in a report on Tuesday, February 17th. Finally, Wells Fargo & Company raised Masimo to a “hold” rating in a report on Wednesday, March 18th. Eight investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $181.17.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.